Contribution of Pannexin1 to Experimental Autoimmune Encephalomyelitis

PLoS ONE

Volumn 8, Issue 6, 2013, Pages

  Lutz, Sarah E ^a,c   González Fernández, Estibaliz ^b   Ventura, Juan Carlos Chara ^b   Pérez Samartín, Alberto ^b   Tarassishin, Leonid ^a   Negoro, Hiromitsu ^a   Patel, Naman K ^a   Suadicani, Sylvia O ^a   Lee, Sunhee C ^a   Matute, Carlos ^b   Scemes, Eliana ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF THE BASQUE COUNTRY UPV EHU   (Spain)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATE; MEFLOQUINE; MEMBRANE PROTEIN; PANNEXIN1; PURINERGIC P2X7 RECEPTOR; UNCLASSIFIED DRUG;

ACUTE DISEASE; ALLERGIC GLOMERULONEPHRITIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CHRONIC DISEASE; CONTROLLED STUDY; DISEASE SEVERITY; DRUG DOSE COMPARISON; FEMALE; KNOCKOUT MOUSE; MALE; MORTALITY; MYELITIS; NONHUMAN; PROTEIN EXPRESSION; RAT; SURVIVAL; SYMPTOM; UPREGULATION; WILD TYPE;

ANIMALS; BASE SEQUENCE; CONNEXINS; DNA PRIMERS; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; INTERLEUKIN-1BETA; MACROPHAGES; MICE; MICE, KNOCKOUT; NERVE TISSUE PROTEINS; REAL-TIME POLYMERASE CHAIN REACTION; RECEPTORS, PURINERGIC P2X7; SPLEEN;

ANIMALIA; MUS;

EID: 84879256660     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0066657     Document Type: Article

References (51)

1. Frohman EM, Racke MK, Raine CS, (2006) Multiple Sclerosis- The plaque and its pathogenesis. N Engl J Med 354: 942-955.
2. Compston A, Coles A, (2008) Multiple sclerosis. Lancet 372: 1502-1517.
3. Domercq M, Perez-Samartin A, Aparicio D, Alberdi E, Pampliega O, Matute C, (2010) P2X7 receptors mediate ischemic damage to oligodendrocytes. Glia 58: 730-740.
4. Matute C, Torre I, Pérez-Cerdá F, Pérez-Samartín A, Alberdi E, et al. (2007) P2X7 receptor blockade prevents ATP excitotoxicity in oligodendrocytes and ameliorates experimental autoimmune encephalomyelitis. J Neurosci 27: 9525-9533.
5. Locovei S, Scemes E, Qiu F, Spray DC, Dahl G, (2007) Pannexin1 is part of the pore forming unit of the P2X7 receptor death complex. FEBS Lett 581: 483-488.
6. Pelegrin P, Barroso-Gutierrez C, Surprenant A, (2008) P2X7 receptor differentially couples to distinct release pathways for IL-1β in mouse macrophage. J Immunol 180: 7147-7157.
7. Iglesias R, Dahl G, Qiu F, Spray DC, Scemes E, (2009) Pannexin 1: The molecular substrate of astrocyte "hemichannels". J Neurosci 29: 7092-7097.
8. Silverman WR, de Rivero Vaccari JP, Locovei S, Qiu F, et al. (2009) The pannexin 1 channel activates the inflammasome in neurons and astrocytes. J Biol Chem 284: 18143-18151.
9. Santiago MF, Veliskova J, Patel NK, Lutz SE, Caille D, et al. (2011) Targeting pannexin1 improves seizure outcome. PLoS ONE 6: e25178.
10. Suadicani SO, Iglesias R, Wang J, Dahl G, Spray DC, et al. (2012) ATP signaling is deficient in cultured pannexin1-null mouse astrocytes. Glia 60: 1106-1116.
11. Bruzzone R, Barbe MT, Jakob NJ, Monyer H, (2005) Pharmacological properties of homomeric and heteromeric pannexin hemichannels expressed in Xenopus oocytes. J Neurochem 92: 1033-1043.
12. Iglesias R, Spray DC, Scemes E, (2009) Mefloquine blockade of pannexin1 currents: Resolution of a conflict. Cell Commun Adhes 16: 131-137.
13. Garré JM, Retamal MA, Cassina P, Barbeito L, Bukauskas FF, et al. (2010) FGF-1 induces ATP release from spinal astrocytes in culture and opens pannexin and connexin hemichannels. Proc Natl Acad Sci U S A 107: 22659-22664.
14. Dvoriantchikova G, Ivanov D, Barakat D, Grinberg A, Wen R, et al. (2012) Genetic ablation of pannexin1 protects retinal neurons from ischemic injury. PLoS ONE 7: e31991.
15. Gulbransen BD, Bashashati M, Hirota SA, Gui X, Roberts JA, et al. (2012) Activation of neuronal P2X7 receptor-pannexin-1 mediates death of enteric neurons during colitis. Nat Med 18: 600-604.
16. Rasband WS (1997-2008) ImageJ. U S National Institutes of Health. Bethesda, Maryland, USA.
17. Rudick RA, Trapp BD, (2009) Gray-matter injury in multiple sclerosis. N Engl J Med 361: 1505-1506.
18. Wujek JR, Bjartmar C, Richer E, Ransohoff RM, Yu M, et al. (2002) Axon loss in the spinal cord determines permanent neurological disability in an animal model of multiple sclerosis. J Neuropathol Exp Neurol 61: 23-32.
19. Papadopoulos D, Pham-Dinh D, Reynolds R, (2006) Axon loss is responsible for chronic neurological deficit following inflammatory demyelination in the rat. Exp Neurol 197: 373-385.
20. Soulika AM, Lee E, McCauley E, Miers L, Bannerman P, et al. (2009) Initiation and progression of axonopathy in experimental autoimmune encephalomyelitis. J Neurosci 29: 14965-14979.
21. Hanstein RN, Negoro H, Patel NK, Charollais A, Meda P, et al. (2013) Promisses and pitfalls of a pannexin1 transgenic mouse line. Front Pharmacol 4: 61.
22. Riffkin CD, Chung R, Wall DM, Zalcberg JR, Cowman AF, et al. (1996) Modulation of the function of human MDR1 P-glycoprotein by the antimalarial drug mefloquine. Biochem Pharmacol 52: 1545-1552.
23. Gillespie RJ, Adams DR, Bebbington D, Benwell K, Cliffe IA, et al. (2008) Antagonists of the human adenosine A2A receptor. Part 1: Discovery and synthesis of thieno[3,2-d]pyrimidine-4-methanone derivatives. Bioorg Med Chem Lett 18: 2916-2919.
24. Yao S-Q, Li Z-Z, Huang Q-Y, Li F, Wang Z-W, et al. (2012) Genetic inactivation of the adenosine A2A receptor exacerbates brain damage in mice with experimental autoimmune encephalomyelitis. J Neurochem 123: 100-112.
25. Kooij G, Backer R, Koning JJ, Reijerkerk A, van Horssen J, et al. (2009) P-glycoprotein acts as an immunomodulator during neuroinflammation. PLoS ONE 4: e8212.
26. Cone AC, Ambrosi C, Scemes E, Martone ME, Sosinsky GE, (2013) A comparative antibody analysis of pannexin1 expression in four rat brain regions reveals varying subcellular localizations. Front Pharmacol 4: 6.
27. Barbe MT, Monyer H, Bruzzone R, (2006) Cell-cell communication beyond connexins: The pannexin channels. Physiology 21: 103-114.
28. Ray A, Zoidl G, Wahle P, Dermietzel R, (2006) Pannexin expression in the cerebellum. Cerebellum 5: 189-192.
29. Schenk U, Westendorf AM, Radaelli E, Casati A, Ferro M, et al. (2008) Purinergic control of T cell activation by ATP released through pannexin-1 hemichannels. Sci Signal 1: ra6.
30. Ferrari D, Chiozzi P, Falzoni S, Dal Susino M, Melchiorri L, et al. (1997) Extracellular ATP triggers IL-1 beta release by activating the purinergic P2Z receptor of human macrophages. J Immunol 159: 1451-1458.
31. Fredholm BB, IJzerman AP, Jacobson KA, Klotz K-N, Linden J, (2001) International Union of Pharmacology. XXV. Nomenclature and Classification of Adenosine Receptors. Pharmacol Rev 53: 527-552.
32. Latini S, Pedata F, (2001) Adenosine in the central nervous system: Release mechanisms and extracellular concentrations. J Neurochem 79: 463-484.
33. Sitkovsky MV, Lukashev D, Apasov S, Kojima H, Koshiba M, et al. (2004) Physiological control of immune response and inflammatory tissue damage by hypoxia-inducible factors and adenosine A2A receptors. Ann Rev Immunol 22: 657-682.
34. Mills JH, Thompson LF, Mueller C, Waickman AT, Jalkanen S, et al. (2008) CD73 is required for efficient entry of lymphocytes into the central nervous system during experimental autoimmune encephalomyelitis. Proc Natl Acad Sci U S A 105: 9325-9330.
35. Chen GQ, Chen YY, Wang XS, Wu SZ, Yang HM, et al. (2010) Chronic caffeine treatment attenuates experimental autoimmune encephalomyelitis induced by guinea pig spinal cord homogenates in Wistar rats. Brain Res 1309: 116-125.
36. Tsutsui S, Schnermann J, Noorbakhsh F, Henry S, Yong VW, et al. (2004) A1 adenosine receptor upregulation and activation attenuates neuroinflammation and demyelination in a model of multiple sclerosis. J Neurosci 24: 1521-1529.
37. Wei W, Du C, Lv J, Zhao G, Li Z, et al. (2013) Blocking A2B adenosine receptor alleviates pathogenesis of experimental autoimmune encephalomyelitis via inhibition of IL-6 production and Th17 dfferentiation. J Immunol 190: 138-146.
38. Martinon F, Burns K, Tschopp J, (2002) The inflammasome: A molecular platform triggering activation of inflammatory caspases and processing of proIL-β. Mol Cell 10: 417-426.
39. Cannella B, Raine CS, (1995) The adhesion molecule and cytokine profile of multiple sclerosis lesions. Ann Neurol 37: 424-435.
40. John GR, Lee SC, Song X, Rivieccio M, Brosnan CF, (2005) IL-1-regulated responses in astrocytes: Relevance to injury and recovery. Glia 49: 161-176.
41. Lalor SJ, Dungan LS, Sutton CE, Basdeo SA, Fletcher JM, et al. (2011) Caspase-1-processed cytokines IL-1β and IL-18 promote IL-17 production by γδ and CD4 T Cells that mediate autoimmunity. J Immunol 186: 5738-5748.
42. Chung Y, Chang SH, Martinez GJ, Yang XO, Nurieva R, et al. (2009) Critical regulation of early Th17 cell differentiation by interleukin-1 signaling. Immunity 30: 576-587.
43. Sutton C, Brereton C, Keogh B, Mills KHG, Lavelle EC, (2006) A crucial role for interleukin (IL)-1 in the induction of IL-17-producing T cells that mediate autoimmune encephalomyelitis. J Exp Med 203: 1685-1691.
44. Narcisse L, Scemes E, Zhao Y, Lee SC, Brosnan CF, (2005) The cytokine IL-1beta transiently enhances P2X7 receptor expression and function in human astrocytes. Glia 49: 245-258.
45. Grygorowicz T, Strużyńska L, Sulkowski G, Chalimoniuk M, Sulejczak D, (2010) Temporal expression of P2X7 purinergic receptor during the course of experimental autoimmune encephalomyelitis. Neurochem Int 57: 823-829.
46. Grygorowicz T, Sulejczak D, Struzynska L, (2011) Expression of purinergic P2X7 receptor in rat brain during the symptomatic phase of experimental autoimmune encephalomyelitis and after recovery of neurological deficits. Acta Neurobiol Exp (Wars) 71: 65-73.
47. Oyanguren-Desez O, Rodríguez-Antigüedad A, Villoslada P, Domercq M, Alberdi E, et al. (2011) Gain-of-function of P2X7 receptor gene variants in multiple sclerosis. Cell Calcium 50: 468-472.
48. Chen L, Brosnan CF, (2006) Exacerbation of experimental autoimmune encephalomyelitis in P2X7R-/- mice: Evidence for loss of apoptotic activity in lymphocytes. J Immunol 176: 3115-3126.
49. Sharp A, Polak P, Simonini V, Lin S, Richardson J, et al. (2008) P2X7 deficiency suppresses development of experimental autoimmune encephalomyelitis. J Neuroinflam 5: 33.
50. Qiu F, Wang J, Dahl G, (2012) Alanine substitution scanning of pannexin1 reveals amino acid residues mediating ATP sensitivity. Purinergic Signal 8: 81-90.
51. Wang J, Jackson DG, Dahl G (2013) The food dye FD&C Blue No. 1 is a selective inhibitor of the ATP release channel Panx1. J Gen Physiol. In press.